Patent details
EP2444079
Title:
Compositions and Methods for Treatment of Eye Disorders
Basic Information
- Publication number:
- EP2444079
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP111810669
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Compositions and Methods for Treatment of Eye Disorders
- French Title of Invention:
- Compositions et procédés pour le traitement des troubles de l'oeil
- German Title of Invention:
- Zusammensetzungen und Verfahren zur Behandlung von Augenerkrankungen
- SPC Number:
-
Dates
- Filing date:
- 17/05/2006
- Grant date:
- 30/11/2016
- EP Publication Date:
- 30/11/2016
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 25/04/2012
- EP B1 Publication Date:
- 30/11/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 17/05/2026
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 28/11/2023
-
-
- Name:
- BAUSCH + LOMB IRELAND LIMITED
- Address:
- Citywest Business Campus, 3013 Lake Drive, Dublin 24, Ireland (IE)
History of Owners
- From:
- 09/04/2020
- To:
- 28/11/2023
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
- From:
- 17/05/2006
- To:
- 09/04/2020
- Name:
- SARcode Bioscience Inc.
- Address:
- 1000 Marina Blvd., Suite 250, Brisbane, CA 94005, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 18/01/2017
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- Gadek Thomas
- Address:
- United States (US)
2
- Name:
- Burnier John
- Address:
- United States (US)
Priority
1
- Priority Number:
- 681772 P
- Priority Date:
- 17/05/2005
- Priority Country:
- United States (US)
2
- Priority Number:
- 681722 P
- Priority Date:
- 17/05/2005
- Priority Country:
- United States (US)
3
- Priority Number:
- 681723 P
- Priority Date:
- 17/05/2005
- Priority Country:
- United States (US)
4
- Priority Number:
- 681684 P
- Priority Date:
- 17/05/2005
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
-
A61K 31/166;
Publication
Bulletin
1
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2020/06
- Publication date:
- 07/05/2020
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
2
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2023/13
- Publication date:
- 07/12/2023
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of ownership
- Deed Number:
- RC20200000109A
- Date Registered:
- 09/04/2020
- Licence Effective Date:
-
- Licence Expiration Date:
-
- Scope of Licence:
-
- Deed Filer:
-
OFFICE FREYLINGER S.A.
- Journal Edition Number:
-
- Text:
-
- Country Code:
-
- Updated Licence Number:
-
- Terminated Licence Number:
-
Added Owner(s)
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Removed Pledgee
- Name:
-
- Address:
Change of owner(s)
- Change Kind/ Decision Type:
- Change of ownership
- Deed Number:
- RC20230000496A
- Date Registered:
- 28/11/2023
- Licence Effective Date:
-
- Licence Expiration Date:
-
- Scope of Licence:
-
- Deed Filer:
-
OFFICE FREYLINGER S.A.
- Journal Edition Number:
-
- Text:
-
- Country Code:
-
- Updated Licence Number:
-
- Terminated Licence Number:
-
Added Owner(s)
- Name:
- BAUSCH + LOMB IRELAND LIMITED
- Address:
- Citywest Business Campus, 3013 Lake Drive, Dublin 24, Ireland (IE)
Removed Pledgee
- Name:
-
- Address:
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 23/04/2025
- Last Annual Fee Paid Number:
- 20
- Last Annual Fee Paid Amount:
- 300 Euro
- Payer:
- ANAQUA SERVICES (ANC. SGA2)